Dr. Reddy's rolls out 2 generics
Dr. Reddy’s is releasing an authorized generic version of USpharma’s NitroDur (nitroglycerin) transdermal infusion system.
Nitrogylcerin transdermal patch products had a market value of approximately $14.7 million for the most recent 12 months ending in January 2020, according to IQVIA.
Dr. Reddy’s product is available in dosage strengths of 0.1 mg/hr, 0.2 mg/hr, 0.4 mg/hr, and 0.6 mg/hr. Each dosage strength comes in a 30 count box.
Dr. Reddy's also is introducing amphetamine sulfate tablets.
The product is the generic of Arbor Pharmaceuticals’ Evekeo (amphetamine sulfate) tablets.
The Evekeo brand and generic had a market value of approximately $38 million for the most recent 12 months ending in January 2020, according to IQVIA.
Dr. Reddy’s amphetamine sulfate tablets are available in dosage strengths of 5 mg and 10 mg dose. The product is available in 100 count bottles.